Kinloch Capital, LLC Sesen Bio, Inc. Transaction History

Kinloch Capital, LLC

  • $203 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$1.3 - $3.24 $2,600 - $6,480
-2,000 Closed
0 $0
Q4 2020

Jan 21, 2021
BUY
$1.01 - $1.77 $2,020 - $3,540
2,000 New
2,000 $3,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Kinloch Capital, LLC Portfolio

Follow Kinloch Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kinloch Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kinloch Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email